Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1

Journal of Computer Assisted Tomography

Volumn 29, Issue 3, 2005, Pages 298-304

  Tognini, Giuseppe ^a   Ferrozzi, Francesco ^a   Garlaschi, Giacomo ^b   Piazza, Paolo ^c   Patti, Arianna ^a   Virdis, Raffaele ^a   Bertolino, Chiara ^c   Bertolino, Giancarlo ^c   Manfredini, Daniele ^d   Zompatori, Maurizio ^a   Crisi, Girolamo ^c  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

Apparent diffusion coefficient; Brain disease; Magnetic resonance diffusion; Neurofibromatosis type 1

Indexed keywords

LOCATION; SURFACE DIFFUSION;

APPARENT DIFFUSION COEFFICIENT; BRAIN DISEASE; COEFFICIENT VALUES; HIGH WATER CONTENT; MAGNETIC RESONANCE DIFFUSION; NEUROFIBROMATOSIS TYPE 1; PEDIATRIC PATIENTS; REGION-OF-INTEREST; REGIONS OF INTEREST; UNIDENTIFIED BRIGHT OBJECTS;

MAGNETIC RESONANCE;

MYELIN; WATER;

ADOLESCENT; ADULT; ARTICLE; BRAIN DISEASE; BRAIN WATER; CELL VACUOLE; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE NUCLEUS; DIFFUSION COEFFICIENT; FEMALE; FRONTAL LOBE; GLOBUS PALLIDUS; GRAY MATTER; HIPPOCAMPUS; HUMAN; MALE; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PONS; PRIORITY JOURNAL; THALAMUS; VISUAL CORTEX; WATER CONTENT; WHITE MATTER;

EID: 21144453961     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000162406.71300.b7     Document Type: Article

References (37)

1. Colman SD, Fallace MR. Neurofibromatosis type 1. Eur J Cancer. 1994; 30:1981-1987.
2. Ferrozzi F, Zuccoli G, Bacchini E, et al. Extracerebral neoplastic manifestations in neurofibromatosis 1: integrated diagnostic imaging. Radiol Med (Torino). 1998;96:562-569.
3. Janss A, Hiehle JF, Yachnis AT. Neurofibromatosis type 1. Med Pediatr Oncol. 1995;25:213-222.
4. Ledbetter DH, Rich DC, O'Connel P, et al. Precise localization of NF1 to 17q11.2 by balanced translocation. Am J Hum Genet. 1989;44:20-24.
5. Robbins SL, Cotran RS, Kumar V. Le basi patologiche delle malattie. Padova: Piccin; 1987.
6. National Institutes of Health. Consensus Development Conference Statement: neurofibromatosis. Neurofibromatosis. 1988;1:172-178.
7. Barkovich AJ. The phakomatoses. In: Barkovich AJ, ed. Pediatric Neuroimaging. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2000: 383-441.
8. Di Paolo DP, Zimmerman RA. The phakomatoses. In: Zimmerman RA, Gibby WA, Carmody RF, eds. Neuroimaging: Clinical and Physical Principles. 1st ed. New York: Springer-Verlag; 2000:657-697.
9. Van Es S, North KN, McHugh K, et al. MRI findings in children with Neurofibromatosis type 1: a prospective study. Pediatr Radiol. 1996;26: 478-487.
10. Menor F, Marti-Bonmati L, Mulas F, et al. Imaging considerations of central nervous system manifestations in paediatric patients with neurofibromatosis type 1. Pediatr Radiol. 1991;21:389-394.
11. Di Paolo DP, Zimmerman RA, Rorke LB, et al. Neurofibromatosis Type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology. 1995;195:721-724.
12. Zimmermann RA, Yachnis AT, Rorke LB, et al. Pathology of findings of cerebral high signal intensity in two patients with type 1 neurofibromatosis [abstract]. Presented at: 78th Scientific Exhibit and Annual Meeting of the Radiological Society of North America. Radiology. 1992; 185(Suppl):123.
13. Sevick RJ, Barkovich AJ, Edwards MSB, et al. Evolution of white matter lesions in Neurofibromatosis type 1: MR findings. AJR Am J Roentgenol, 1992;159:171-175.
14. Mirowitz SA, Sartor K, Gado M. High-intensity basal ganglia lesions on T1 weighted MR images in neurofibromatosis. AJR Am J Roentgenol. 1989;154:369-373.
15. Menor F, Marti-Bonmati L, Arana E, et al. Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings. Eur J Radiol. 1998;26:121-131.
16. Itoh T, Magnaldi S, White RM, et al. Neurofibromatosis type 1: the evolution of deep grey and white matter abnormalities. AJNR Am J Neuroradiol. 1994;15:1513-1519.
17. Barkovich AJ, Kjos BO, Jackson DE, et al. Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. Radiology. 1988;166: 173-180.
18. Shaefer PW, Grant PE, Gonzalez RG. Diffusion weighted MR imaging of the brain. Radiology. 2000;217:331-345.
19. Medina LS. Changes in brain water diffusion during the 1st year of life: finally starting to understand age- and brain tissue-related normative data. Radiology. 2002;222:316-318.
20. Weimberger DM, Roberts TP, Barkovich AJ, et al. Identification of "premyelination" by diffusion weighted MRI. J Comput Assist Tomogr. 1995;19:28-33.
21. Morriss MC, Zimmerman RA, Bilaniuk LT, et al. Changes in brain water diffusion during childhood. Neuroradiology. 1999;41:929-934.
22. Mukherjee P, Miller JH, Shimony JS, et al. Normal brain maturation during childhood: developmental trends characterized with diffusion tensor MR imaging. Radiology. 2001;221:349-358.
23. Takeda K, Nomura Y, Sakuma H, et al. MR assessment of normal brain development in neonates and infants: comparative study of T1 and diffusion weighted images. J Comput Assist Tomogr. 1997;21:1-7.
24. Wimberger DM, Roberts TP, Barkovich AJ, et al. Identification of "premyelination" by diffusion weighted MRI. J Comput Assist Tomogr. 1995;19:28-33.
25. Forbes KPN, Pipe JG, Bird CR. Changes in brain water diffusion during the 1st year of life. Radiology. 2002;222:405-409.
26. Helenius J, Soinne L, Perkiö J, et al. Diffusion-weighted MR imaging in normal human brains in various age groups. AJNR Am J Neuroradiol. 2002;23:194-199.
27. Toft PB, Leth H, Peitersen B, et al. The apparent diffusion coefficient of water in grey and white matter of the infant brain. J Comput Assist Tomogr. 1996;20:1006-1011.
28. Neil JJ, Shiran SI, McKinstry RC, et al. Normal brain in human newborns: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging. Radiology. 1998;209:57-66.
29. Tanner SF, Ramenghi LA, Ridgway JP, et al. Quantitative comparison of intrabrain diffusion in adults and preterm and term neonates and infants. AJR Am J Roentgenol. 2000;174:1643-1649.
30. Engelbrecht V, Scherer A, Rassek M, et al. Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology. 2002;222:410-418.
31. Eastwood JD, Fiorella DJ, MacFall JF, et al. Increased brain apparent diffusion coefficient in children with Neurofibromatosis type 1. Radiology. 2001;219:354-358.
32. Gonen O, Wang ZJ, Viswanathan AK, et al. Three-dimensional multivoxel proton MR spectroscopy of the brain in children with Neurofibromatosis type 1. AJNR Am J Neuroradiol. 1999;20:1333-1341.
33. 1H spectroscopy evidence for the varied nature of asymptomatic focal brain lesions in neurofibromatosis type 1. Neuroradiology. 2001;43:62-67.
34. Wang PY, Kaufmann WE, Koth CW, et al. Thalamic involvement in Neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging. Ann Neurol. 2000;47:477-484.
35. Sakuma H, Nomura Y, Takeda K, et al. Adult and neonatal human brain: diffusional anisotropy and myelination with diffusion weighted MR imaging. Radiology. 1991;180:229-233.
36. Hüppi PS, Maier SE, Peled S, et al. Microstructural development of human newborn cerebral white matter assessed in vivo by diffusion tensor magnetic resonance imaging. Pediatr Res. 1998;44:585-590.
37. Baratti C, Barnett AS, Pierpaoli C. Comparative MR imaging study of brain maturation in kittens with T1, T2, and trace of diffusion tensor. Radiology. 1999;210:133-142.